Reuters logo
BRIEF-Recro Pharma presents Phase III bunionectomy clinical data for IV meloxicam
May 18, 2017 / 12:18 PM / 6 months ago

BRIEF-Recro Pharma presents Phase III bunionectomy clinical data for IV meloxicam

May 18 (Reuters) - Recro Pharma Inc

* Recro Pharma presents Phase III bunionectomy clinical data for IV meloxicam at the American Pain Society 36th annual scientific meeting

* Recro Pharma - data from late-stage trial demonstrate iv meloxicam 30mg provides rapid and sustained pain relief following bunionectomy surgery Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below